Drug-polypeptide self-assembled nanoparticles and preparation method thereof
A nanoparticle and self-assembly technology, which can be used in drug combination, drug delivery, and pharmaceutical formulations. It can solve the problems of early release, low water solubility, and low structural stability, and achieve low toxicity and high water solubility.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
preparation example Construction
[0041] A preparation method of drug-polypeptide self-assembled nanoparticles, comprising the steps of:
[0042] (1) Synthetic prodrug, prodrug is synthesized by hydrophobic small molecule drug, phenylalanine dipeptide, hydrophilic group, described hydrophobic small molecule drug is triptolide, camptothecin, paclitaxel, doxorubicin At least one of the hormones, the hydrophilic group is glucosamine.
[0043] Including the following steps:
[0044] a. prepare amino-phenylalanine dipeptide-glucosamine;
[0045] b. Preparation of carboxyl hydrophobic small molecule drugs;
[0046] c. Obtain the product hydrophobic small molecule drug-phenylalanine dipeptide-glucosamine.
[0047] (2) The prodrug is added into the aqueous solution to self-assemble to obtain nanoparticles.
Embodiment 1
[0049] Example 1 Synthesis of prodrug: triptolide-diphenylalanine-glucose.
[0050] The preparation method of triptolide-diphenylalanine-glucose comprises the following steps, such as figure 1 Shown:
[0051] (1) tert-butoxycarbonyl-phenylalanine dipeptide-glucosamine (Boc-Phe-Phe-OH), 1-ethyl-3-(3-di Methylaminopropyl) carbodiimide and N-hydroxysuccinimide are dissolved together;
[0052] (2) Anhydrous dimethylformamide (DMF) solution dissolved with glucosamine and triethylamine (TEA) is added dropwise to the above solution;
[0053] (3) After the above mixture was evaporated under reduced pressure for 20-28 hours, the product tert-butoxycarbonyl-phenylalanine dipeptide-glucosamine (BOC-FF-AG) was obtained;
[0054] (4) Dissolve tert-butoxycarbonyl-phenylalanine dipeptide-glucosamine (BOC-FF-AG) in a mixture of equal volumes of anhydrous dichloromethane and trifluoroacetic acid, and stir at room temperature for 3- 6 hours;
[0055] (5) After the above solution is evapora...
Embodiment 2
[0062] Example 2 Triptolide Nanomedicine In Vivo Drug Toxicity Analysis
[0063] Male BALB / c mice were randomly divided into four groups, and were injected intravenously with PBS buffer solution (PBS), triptolide (triptolide), triptolide nano-medicines (TPNs) and erythrocyte membrane Bionic triptolide nano-medicine (manRTPNs), the drug-polypeptide self-assembled nanoparticles in the present invention are Figure 7 Membrane-inspired triptolide nanomedicines (manRTPNs) in.
[0064] After continuous injection for one week, all mice were euthanized, blood was collected for blood routine examination and biochemical parameter measurement, and major organs such as heart, liver, spleen, lung and kidney were excised and H&E stained for histological examination and analysis . The result is as Figure 7 As shown, the number of blood cells including leukocytes, erythrocytes and platelets decreased significantly after the former drug of triptolide was treated, indicating that it has sid...
PUM
Property | Measurement | Unit |
---|---|---|
diameter | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com